1. A cell-engineered system to assess tumor cell sensitivity to CD8 + T cell-mediated cytotoxicity
   Nadine Nelson et al, 2019, OncoImmunology CrossRef
2. A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL
   Baojie Zhang et al, 2020, Biochemical Pharmacology CrossRef
3. Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis
   Neal Shah et al, 2020, BMC Cancer CrossRef
4. Design, synthesis and biological evaluation of structurally new 4-indolyl quinazoline derivatives as highly potent, selective and orally bioavailable EGFR inhibitors
   Pengxing He et al, 2024, Bioorganic Chemistry CrossRef
5. Dynamic EGFR interactomes reveal differential association of signaling modules with wildtype and Exon19-del EGFR in NSCLC cell lines
   Xiaofeng Zhang et al, 2022, Journal of Proteomics CrossRef
6. Imaging analysis of EGFR mutated cancer cells using peptide nucleic acid (PNA)–DNA probes
   Hajime Shigeto et al, 2019, The Analyst CrossRef
7. Construction of the model for predicting prognosis by key genes regulating EGFR-TKI resistance
   Jinke Zhuge et al, 2022, Frontiers in Genetics CrossRef
8. Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo
   Zhongwei Liu et al, 2021, Archives of Toxicology CrossRef
9. Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer Activity
   Na Young Kim et al, 2022, Molecules CrossRef